- Home
- WNEB vs GNFT Comparison
WNEB vs GNFT Comparison
Compare WNEB & GNFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WNEB
- GNFT
- Stock Information
- Founded
- WNEB 1853
- GNFT 1999
- Country
- WNEB United States
- GNFT France
- Employees
- WNEB N/A
- GNFT N/A
- Industry
- WNEB Savings Institutions
- GNFT Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- WNEB Finance
- GNFT Health Care
- Exchange
- WNEB Nasdaq
- GNFT Nasdaq
- Market Cap
- WNEB 195.7M
- GNFT 216.7M
- IPO Year
- WNEB N/A
- GNFT 2019
- Fundamental
- Price
- WNEB $11.36
- GNFT $4.30
- Analyst Decision
- WNEB Buy
- GNFT Strong Buy
- Analyst Count
- WNEB 2
- GNFT 2
- Target Price
- WNEB $11.00
- GNFT $10.00
- AVG Volume (30 Days)
- WNEB 48.8K
- GNFT 7.5K
- Earning Date
- WNEB 10-22-2025
- GNFT 09-22-2025
- Dividend Yield
- WNEB 2.47%
- GNFT N/A
- EPS Growth
- WNEB N/A
- GNFT N/A
- EPS
- WNEB 0.59
- GNFT N/A
- Revenue
- WNEB $76,036,000.00
- GNFT $52,994,715.00
- Revenue This Year
- WNEB N/A
- GNFT $3.14
- Revenue Next Year
- WNEB $7.36
- GNFT N/A
- P/E Ratio
- WNEB $19.27
- GNFT N/A
- Revenue Growth
- WNEB 2.15
- GNFT N/A
- 52 Week Low
- WNEB $7.63
- GNFT $2.55
- 52 Week High
- WNEB $12.80
- GNFT $6.03
- Technical
- Relative Strength Index (RSI)
- WNEB 46.21
- GNFT 57.06
- Support Level
- WNEB $10.78
- GNFT $4.08
- Resistance Level
- WNEB $11.44
- GNFT $4.36
- Average True Range (ATR)
- WNEB 0.33
- GNFT 0.18
- MACD
- WNEB -0.01
- GNFT 0.03
- Stochastic Oscillator
- WNEB 43.46
- GNFT 74.14
About WNEB Western New England Bancorp Inc.
Western New England Bancorp Inc through its bank subsidiary, provides a range of financial services to individuals and companies in western Massachusetts and northern Connecticut. These services include commercial lending, residential lending and consumer lending, checking, savings and time deposits, cash management, and wealth management. Substantially all of the company's revenues, profits, and assets are derived by the Bank from banking products and services.
About GNFT GENFIT S.A.
Genfit SA is a biotechnology company focused on metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology. The company's research and development activity relies on its expertise in modulating gene expression through nuclear receptors. Genfit utilizes acquisitions, strategic alliances, and licensing agreements in order to fund the further development of its products. It has one segment the research and development of medicines and diagnostic solutions, the marketing of which depends on the success of the clinical development phase.